Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay

Feasibility Study on Measuring Selected Proteins in Malignant Melanoma Tissue by SRM Quantification

(2014) Charlotte Welinder et al.   JOURNAL OF PROTEOME RESEARCH

α-Synuclein: The Long Distance Runner

(2013) Sonia George et al.   BRAIN PATHOLOGY

Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies

(2013) Adrien W. Schmid et al.   MOLECULAR & CELLULAR PROTEOMICS

Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders

(2013) Rafael Tabarés-Seisdedos et al.   NATURE REVIEWS NEUROSCIENCE

Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration

(2013) Joseph McInnes   Translational Neurodegeneration

α-Synuclein oligomers and clinical implications for Parkinson disease

(2012) Lorraine V. Kalia et al.   ANNALS OF NEUROLOGY

Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions

(2012) Paola Picotti et al.   NATURE METHODS

ExPASy: SIB bioinformatics resource portal

(2012) P. Artimo et al.   NUCLEIC ACIDS RESEARCH

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression

(2011) Jesse R. McLean et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

The yin and yang of amyloid: insights from α-synuclein and repeat domain of Pmel17

(2011) Ryan P. McGlinchey et al.   PHYSICAL CHEMISTRY CHEMICAL PHYSICS

Evaluation of absolute peptide quantitation strategies using selected reaction monitoring

(2011) James Campbell et al.   PROTEOMICS

Increased Melanoma Risk in Parkinson Disease

(2010) John M. Bertoni   ARCHIVES OF NEUROLOGY

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

(2010) Brendan MacLean et al.   BIOINFORMATICS

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Detection of elevated levels of  -synuclein oligomers in CSF from patients with Parkinson disease

(2010) T. Tokuda et al.   NEUROLOGY

Common pathogenic pathways in melanoma and Parkinson disease

(2010) C. Paisan-Ruiz et al.   NEUROLOGY

Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma

(2010) Yasuhiro Matsuo et al.   PLoS One

 -Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro

(2010) J. Burre et al.   SCIENCE

α-Synuclein and neuronal cell death

(2009) Mark R Cookson   Molecular Neurodegeneration

High-throughput generation of selected reaction-monitoring assays for proteins and proteomes

(2009) Paola Picotti et al.   NATURE METHODS

Family history of melanoma and Parkinson disease risk

(2009) X. Gao et al.   NEUROLOGY

PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows

(2008) Eric W Deutsch et al.   EMBO REPORTS

Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

(2008) Brit Mollenhauer et al.   EXPERIMENTAL NEUROLOGY

Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood

(2008) Robin Barbour et al.   Neurodegenerative Diseases

Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?

(2008) Annika Öhrfelt et al.   NEUROSCIENCE LETTERS

Novel MITF targets identified using a two-step DNA microarray strategy

(2008) Keith S. Hoek et al.   Pigment Cell & Melanoma Research